At a glance
- Originator Scios
- Developer Nonindustrial source; Scios
- Class Analgesics; Antihypertensives; Imidazoles; Spiro compounds
- Mechanism of Action Bradykinin B2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation; Pain
Most Recent Events
- 02 Sep 1998 No-Development-Reported for Inflammation in Brazil (Unknown route)
- 02 Sep 1998 No-Development-Reported for Inflammation in USA (Unknown route)
- 02 Sep 1998 No-Development-Reported for Pain in Brazil (Unknown route)